Skip to main content
Erschienen in: BMC Psychiatry 1/2023

Open Access 01.12.2023 | Research

A comparison of clinical characteristics of psychiatric inpatients in three hospitals from Western China and America

verfasst von: Min Jia, Bang An, Bin Yan, Qingyan Ma, Binglong Wen, Shanshan Zhao, Chengge Gao, Xiancang Ma, Lili Zhang, Bin Li, Ping Zhang, Jian Wang, Hong Yu, Wei Wang

Erschienen in: BMC Psychiatry | Ausgabe 1/2023

Abstract

Background

Different countries have differences in social and cultural context and health system, which may affect the clinical characteristics of psychiatric inpatients. This study was the first to compare cross-cultural differences in the clinical characteristics of psychiatric inpatients in three hospitals from Western China and America.

Methods

Overall, 905 and 1318 patients from three hospitals, one in America and two in Western China, respectively, were included. We used a standardised protocol and data collection procedure to record inpatients’ sociodemographic and clinical characteristics.

Results

Significant differences were found between hospitals from the two countries. Positive symptoms were the main reason for admission in the Chinese hospitals, while reported suicide and self-injury symptoms more frequently led to hospital admission in America. Moreover, there were more inpatients with combined substance abuse in the American hospital (97.6% vs. 1.9%, P < 0.001). The length of stay (LOS) in America was generally shorter than in China (10.5 ± 11.9 vs. 20.7 ± 13.4, P < 0.001). The dosage of antipsychotic drugs used in the American hospital was higher than in China (275.1 ± 306.9 mg vs. 238.3 ± 212.5 mg, P = 0.002). Regression analysis showed that male sex, older age, retirees, being admitted because of physical symptoms, and using higher doses of antipsychotic drugs were significantly associated with longer hospitalisation in the American hospital (P < 0.05). Comparatively, patients who were divorced, experiencing suicidal ideation, admitted involuntarily, admitted because of physical, depression, or anxiety symptoms, and using higher doses of antipsychotic drugs had longer hospitalisation in Chinese hospitals (P < 0.05).

Conclusion

Significant variations in clinical characteristics of inpatients were found between hospitals from Western China and America. The LOS in Chinese hospitals was significantly longer, but patients used higher doses of antipsychotic drugs in the American hospital. Admission due to physical symptoms and the use of higher dosage drugs were related to longer LOS in both countries.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12888-022-04500-2.
Min Jia and Bang An contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ICD-10
International Classification of Diseases Tenth Revision
DSM-5
The Diagnostic and Statistical Manual of Mental Disorders
CPZeq
Chlorpromazine equivalent milligrams
LOS
Length of stay

Introduction

In recent decades, mental health service systems in China and America have made substantial advances with economic and cultural development [1, 2]. Different cultural backgrounds, management systems, treatment patterns, and other factors can affect clinical characteristics of psychiatric inpatients.
The Chinese Mental Health Survey in 2019 showed that the prevalence of most mental disorders has increased; the weighted lifetime prevalence of six major types of mental disorders, excluding dementia, was 16.6%. The most common disorders were anxiety disorders (7.6%), followed by mood disorders (7.4%), substance use disorders (4.7%), impulse control disorders (1.5%), and schizophrenia and other psychotic disorders (0.7%) [3]. The above results also indicate that the prevalence of schizophrenia remains globally unchanged [4]. Comparatively, the survey of American adolescents showed that anxiety disorders were the most common condition (31.9%), followed by behaviour (19.1%), mood (14.3%), and substance use (11.4%) disorders; the comorbidity rate that meets the diagnosis of both mental disorders was approximately 40% [5]. The above survey emphasized that we should shift our attention from the treatment of American youth to prevention and early intervention.
As a representative of western countries, America began to reduce the number of large psychiatric hospitals and transform them into community services many years ago. Furthermore, mental hospitals have been replaced by psychiatric outpatients at general hospitals [6]. With the development of this ‘deinstitutionalisation’, more patients return to society and recover better; however, there is also evidence that this deinstitutionalisation increases the risk of violent crime [7]. The mental health service system in China has also learned from the experiences of other developed countries. Consequently, after continuous efforts, the number of registered psychiatric doctors and psychiatric hospital beds has increased significantly. However, compared with the large population of patients in China, there is still a limited number of hospital beds [8]. Mental health services rely on mental health hospitals and are separate from the community. This model is not beneficial for the long-term development of patients and increases the burden on the country [9]. Since 2004, China has implemented a national community service model called the National Continuing Management and Intervention Program for Psychoses (686 Program) [1], that has helped patients receive systematic treatment and follow-up.
However, both countries differ in their social and cultural context, health system, and clinical practice, which may affect the clinical characteristics of psychiatric inpatients. To date, no studies have compared the medical information of psychiatric inpatients between hospitals from Western China and America. The aim of this study was thus to address this gap by comparing the differences in clinical characteristics of psychiatric inpatients from three hospitals in these two countries, to provide some references for further research.

Methods

Research design and subjects

The Chinese information was obtained from the psychiatric department of two tertiary hospitals in Shaanxi Province: The First Affiliated Hospital of Xi’an Jiao Tong University and Xianyang Central Hospital, both of which are general hospitals. The American data were obtained from a general hospital with a psychiatric ward located at Buffalo, University at Buffalo-Psychiatry, Erie County Medical Center. All three hospitals have established hospital information systems, from which major information on clinical characteristics was obtained.
Data were collected by reviewing medical records. Using a form designed specifically for this study, information was collected between January and December 2015 from inpatients who were hospitalised in these hospitals. Sociodemographic information included gender, age, marital status, education level, occupation, and living conditions. Medical information mainly comprised reasons for hospitalisation, which was determined by several experienced experts on the basis of review and discussion of previous medical records (If a patient was admitted with plural reasons, the most prominent symptom was defined as the reason for hospitalization), whether they were admitted voluntarily, whether they were restrained or isolated during hospitalisation, existing condition with substance abuse, suicidal ideation, insurance, diagnosis with International Classification of Diseases Tenth Revision (ICD-10) or The Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5), the diagnosis was confirmed by at least two well-trained psychiatrists, and the length of stay (LOS) and antipsychotic drug dosage (the dosage here refers to the final stable daily dosage). Antipsychotic dosages were converted into chlorpromazine equivalent milligrams (CPZeq) [10, 11]. Owing to the anonymous nature of the retrospective chart review and for the purpose of clinical review, informed consent was not required, which was consistent with local ethical standards; only the medical records were reviewed. The study was approved by the Medical Ethics Committees of these hospitals.

Statistical analyses

All statistical analyses were performed using SPSS 24.0. A t-test was used to compare continuous variables, a chi-square test and Fisher’s exact test were used to compare categorical variables. First, univariable factor linear regression analysis was used to screen variables affecting LOS. Then, the variables with statistical significance in the univariable regression analysis were included into new multivariable linear regression models to analyze variables affecting LOS in Western China and America, respectively. Moreover, the one-sample Kolmogorov-Smirnov test was used to check the normality of the distribution for the continuous variables. All statistical tests were two-sided, and a P-value < 0.05 was considered statistically significant.

Results

Socio-demographic characteristics of psychiatric inpatients

Inpatients’ socio-demographic characteristics in China and America are summarised in Table 1. A total of 2223 patients’ data, 905 from the American hospital and 1318 from the Chinese hospitals, were reviewed. In America, the proportion of male patients in psychiatric hospitals (62.1%) was significantly higher than females (37.9%). Comparatively, in China, the proportion of female patients (57.1%) was higher than male patients (42.9%). The proportion of unmarried inpatients in America was the highest (76.7%), while nearly half of the inpatients in the Chinese hospitals were married (59.1%), which accounted for the highest proportion. Patients with high school education levels were the highest in both countries (56.8% in America and 34.4% in China). The proportion of unemployed patients in the American (84.4%) was higher than in Chinese hospitals (11.2%). In both countries, most patients lived with their families; however, the proportion in the Chinese hospitals was higher than in America (99.7% vs 70.7%, P < 0.001).
Table 1
Socio-Demographic of psychiatric inpatients in western China and America
 
America
(N = 905)
China
(N = 1318)
t/χ2
P
Age (years, \(\overline{x}\) ±s)
39.7 ± 13.7
40.3 ± 18.6
0.906
0.365
Gender, n (%)
  
78.772
<0.001
 Male
562 (62.1%)
566 (42.9%)
  
 Female
343 (37.9%)
752 (57.1%)
  
Marital status, n (%)
  
498.645
<0.001
 Unmarried
694 (76.7%)
463 (35.1%)
  
 Married
112 (12.4%)
779 (59.1%)
  
 Divorce
79 (8.7%)
44 (3.3%)
  
 Widowed
20 (2.2%)
32 (2.4%)
  
Education, n (%)
  
429.311
<0.001
 Primary school and below
7 (0.8%)
238 (18.1%)
  
 Junior middle school
36 (4.0%)
355 (26.9%)
  
 High school
514 (56.8%)
453 (34.4%)
  
 Junior college or undergraduate
348 (38.5%)
272 (20.6%)
  
Occupation, n (%)
  
1276.030
<0.001
 Workers
106 (11.7%)
227 (17.2%)
  
 Freelance worker
5 (0.6%)
496 (37.6%)
  
 Students
10 (1.1%)
181 (13.7%)
  
 Retiree
20 (2.2%)
267 (20.3%)
  
 The unemployed
764 (84.4%)
147 (11.2%)
  
Living condition, n (%)
  
423.615
<0.001
 Living alone
265 (29.3%)
4 (0.3%)
  
 Groups life
640 (70.7%)
1314 (99.7%)
  
N total number of subjects in the study cohort; n (%) number (percentage) of patients with the indicated characteristic

Clinical characteristics of psychiatric inpatients

Table 2 presents the clinical characteristics of the psychiatric inpatients. The reasons for admission differed, with suicide and self-injury symptoms accounting for the largest proportion in the American hospital (46.1%), which was much higher than in China (7%), followed by positive symptoms (44.9%). In the Chinese hospitals, the main reason for admission was positive symptoms (46.3%). Most patients were admitted involuntarily in America (94.1%), and voluntarily (64.5%) in China. Moreover, the proportions of patients who were restrained or isolated in these two countries were below 15% (13.7% in America and 13.1% in China, P = 0.657). Compared with China, there were more inpatients with combined substance abuse in America (97.6% vs 1.9%, P < 0.001). Among them, 54.3% of patients combined alcohol and drug abuse and 43.3% combined narcotics. In the Chinese hospitals, only 1.9% of patients had combined substance abuse and no inpatients had combined narcotics. In both countries, more than 90% of patients had insurance (98.6% in America and 99.3% in China, P = 0.078).
Table 2
Clinical characteristics of psychiatric inpatients in western China and America
 
America
(N = 905)
China
(N = 1318)
t/χ2
P
Reasons for admission, n (%)
  
622.279
<0.001
 Positive symptoms
406 (44.9%)
610 (46.3%)
  
 Negative symptoms
6 (0.7%)
67 (5.1%)
  
 Depression and anxiety
43 (4.8%)
379 (28.8%)
  
 Suicide and self-injury
417 (46.1%)
92 (7.0%)
  
 Physical symptoms
18 (2.0%)
157 (11.9%)
  
 Substance abuse
9 (1.0%)
8 (0.6%)
  
 Drug side effects
6 (0.7%)
5 (0.4%)
  
Whether or not to be admitted voluntarily, n (%)
  
764.821
<0.001
 Yes
53 (5.9%)
850 (64.5%)
  
 No
852 (94.1%)
468 (35.5%)
  
Whether restrained or isolated, n (%)
  
0.197
0.657
 Yes
124 (13.7%)
172 (13.1%)
  
 No
781 (86.3%)
1146 (86.9%)
  
Substance abuse, n (%)
  
2034.822
<0.001
 None
22 (2.4%)
1293 (98.1%)
  
 Substance abuse
883 (97.6%)
25 (1.9%)
  
  Alcohol and Drugs
491 (54.3%)
25 (1.9%)
  
  Narcotics
392 (43.3%)
0 (0.0%)
  
Suicidal ideation, n (%)
  
2.807
0.094
 Yes
466 (51.5%)
631 (47.9%)
  
 No
439 (48.5%)
687 (52.1%)
  
Insurance, n (%)
  
3.110
0.078
 Yes
892 (98.6%)
1309 (99.3%)
  
 No
13 (1.4%)
9 (0.7%)
  
Diagnosis, n (%)
  
183.445
<0.001
 Organic mental disorder
29 (3.2%)
252 (19.1%)
  
 Mental and behavioral disorders due to psychoactive substance use
41 (4.5%)
10 (0.8%)
  
 Schizophrenia Spectrum Disorder
341 (37.7%)
454 (34.4%)
  
 Mood disorder
326 (36.0%)
345 (26.2%)
  
  Depression
176 (19.4%)
199 (15.1%)
  
  Bipolar disorder
150 (16.6%)
146 (11.1%)
  
Neurotic, stress-related and somatoform disorders
160 (17.7%)
221 (16.8%)
  
Behavioral syndrome with physiological disorders and somatic factors
1 (0.1%)
16 (1.2%)
  
Personality and behavioral disorders
6 (0.7%)
2 (0.2%)
  
Intellectual disability
1 (0.1%)
7 (0.5%)
  
Mental development disorder
0 (0.0%)
11 (0.8%)
  
LOS (days, \(\overline{x}\) ±s)
10.5 ± 11.9
20.7 ± 13.4
18.719
<0.001
 Organic mental disorder
9.9 ± 18.1
20.2 ± 12.3
4.023
<0.001
 Mental and behavioral disorders due to psychoactive substance use
7.3 ± 5.4
13.9 ± 5.3
3.519
0.001
 Schizophrenia Spectrum Disorder
13.8 ± 13.8
22.4 ± 16.0
7.983
<0.001
 Mood disorders
    
  Depression
8.6 ± 8.9
19.7 ± 10.1
11.251
<0.001
  Bipolar disorder
10.3 ± 8.1
23.3 ± 16.0
8.842
<0.001
Neurotic, stress-related and somatoform disorders
6.8 ± 11.9
17.1 ± 8.0
10.129
<0.001
Behavioral syndrome with physiological disorders and somatic factors
9.0 ± 0.0
17.3 ± 8.7
0.926
0.369
Personality and behavioral disorders
8.7 ± 5.1
13.5 ± 10.6
0.932
0.387
Intellectual disability
30.0 ± 0.0
23.3 ± 5.3
−1.189
0.279
Mental development disorder
21.3 ± 16.9
Total dose of antipsychotics (mg, \(\overline{x}\) ±s)
275.1 ± 306.9
238.3 ± 212.5
−3.129
0.002
 Organic mental disorder
133.0 ± 152.1
155.6 ± 135.1
0.840
0.402
 Mental and behavioral disorders due to psychoactive substance use
153.2 ± 191.7
261.0 ± 228.5
1.537
0.131
 Schizophrenia Spectrum Disorder
447.2 ± 329.0
386.2 ± 216.3
−2.973
0.003
 Mood disorder
    
  Depression
77.0 ± 124.5
117.7 ± 108.7
3.383
<0.001
  Bipolar disorder
364.8 ± 296.0
280.2 ± 212.9
−2.831
0.005
Neurotic, stress-related and somatoform disorders
99.0 ± 189.2
118.8 ± 156.1
1.118
0.264
Behavioral syndrome with physiological disorders and somatic factors
420.0 ± 0.0
120.1 ± 109.2
−2.665
0.018
Personality and behavioral disorders
222.5 ± 240.1
300.0 ± 424.3
0.340
0.746
Intellectual disability
510.0 ± 0.0
285.7 ± 163.2
−1.285
0.246
Mental development disorder
169.6 ± 139.4
N total number of subjects in the study cohort; n (%) number (percentage) of patients with the indicated characteristic
Moreover, schizophrenia was the most evident diagnosis in both countries (37.7% in America and 34.4% in China), followed by mood disorders (36.0% in America and 26.2% in China). The proportion of organic mental disorder patients in Chinese hospitals was higher than in America (19.1% vs 3.2%, P < 0.001) but that of psychoactive substances in America was higher than in China (4.5% vs 0.8%, P < 0.001). Patients diagnosed with behavioural syndrome with physiological disorders and somatic factors, personality and behavioural disorders, intellectual disability, and mental development disorders were less than 5% in both countries. Owing to the few patients diagnosed with these diseases, they were excluded when comparing the LOS. Overall, the LOS in hospitals in America was shorter than in China (10.5 ± 11.9 vs 20.7 ± 13.4, P < 0.001). Individuals with schizophrenia had the longest hospitalisation in America (13.8 ± 13.8), followed by bipolar disorder (10.3 ± 8.1). In China, the longest hospitalisation was for bipolar disorder (23.3 ± 16.0), followed by schizophrenia (22.4 ± 16.0). In general, excluding the above-mentioned four diseases, the total dosage of antipsychotic drugs used in the American hospital was higher than in China (275.1 ± 306.9 mg vs 238.3 ± 212.5 mg, P = 0.002). In America, the dosage of antipsychotic drugs in patients with schizophrenia spectrum disorder (447.2 ± 329.0 mg vs 386.2 ± 216.3 mg, P = 0.003) and bipolar disorder (364.8 ± 296.0 mg vs 280.2 ± 212.9 mg, P = 0.005) was higher than in China. However, it is worth noting that the dosage of antipsychotic drugs used by patients with unipolar depression in Chinese hospitals was higher than in America (117.7 ± 108.7 mg vs 77.0 ± 124.5 mg, P < 0.001). Overall, patients with schizophrenia had the largest dosage of antipsychotic drugs in both countries (447.2 ± 329.0 mg in America and 386.2 ± 216.3 mg in China), followed by bipolar disorder (364.8 ± 296.0 mg in America and 280.2 ± 212.9 mg in China).

Factors affecting LOS

Table 3 presents the regression analysis results in the American hospital. In univariable analysis, we found that nine variables were significantly associated with the LOS. We then conducted a multivariable regression analysis of these variables and found that males, older patients, retirees, patients admitted because of physical symptoms, and patients who used higher dosages of antipsychotic drugs had significantly longer LOS (P < 0.05). Stratified by gender, we found that male inpatients had more severe symptoms and took higher doses drugs (Supplementary Table).
Table 3
Mixed linear regression model testing associations of predictors with LOS in American hospital
Variables
Univariable linear regression
Multivariable linear regression
β
Cl(95%)
P
β
Cl(95%)
p
Lower bound
Upper bound
Lower bound
Upper bound
Age
0.143
0.087
0.199
<0.001
0.144
0.082
0.205
<0.001
aGender
−2.945
−4.536
−1.354
<0.001
−2.078
−3.635
−0.521
0.009
bMarital status
        
 Unmarried
2.503
0.124
4.881
0.039
1.656
−0.670
3.982
0.163
 Divorce
2.321
−1.111
5.753
0.185
1.201
−1.993
4.396
0.461
 Widowed
1.575
−4.095
7.245
0.586
−1.018
−6.322
4.287
0.707
cEducation
        
 Junior middle school
4.056
−5.578
13.689
0.409
    
 High school
3.325
−5.550
12.199
0.462
    
 Junior college or undergraduate
1.253
−7.650
10.156
0.782
    
dOccupation
        
 Workers
−14.471
−20.097
−8.844
<0.001
−10.596
−16.171
−5.021
<0.001
 Freelance worker
−17.250
− 28.789
− 5.711
<0.003
− 11.526
− 22.429
−0.622
0.038
 Students
−15.750
− 24.688
−6.812
0.001
− 10.967
−19.761
− 2.173
0.015
 The unemployed
−12.028
−17.256
−6.801
<0.001
−9.761
−14.956
−4.566
<0.001
eLiving condition
        
 Groups life
0.901
−0.807
2.608
0.301
    
fSubstance abuse
        
 Yes
−5.139
−10.176
−0.102
0.046
    
gSuicidal ideation
        
 Yes
4.001
2.467
5.534
<0.001
−0.434
−3.493
2.626
0.781
hInsurance
        
 Yes
6.471
−0.050
12.991
0.052
    
iWhether or not to be admitted voluntarily
        
 Yes
−1.206
−4.516
2.104
0.475
    
jWhether restrained or isolated
        
 Yes
3.524
1.275
5.773
<0.002
0.379
−1.958
2.716
0.751
kReasons for hospitalization
        
 Negative symptoms
2.584
−6.805
11.972
0.589
5.493
−3.439
14.425
0.228
 Depression and anxiety
−1.649
−5.310
2.012
0.377
1.466
−2.194
5.125
0.432
 Suicide and self-injury
−4.138
−5.730
−2.546
<0.001
−0.609
−3.858
2.639
0.713
 Physical symptoms
10.195
4.696
15.694
<0.001
9.720
4.515
14.926
<0.001
 Substance abuse
−7.750
−15.443
−0.056
0.048
−4.810
− 12.410
2.790
0.215
 Drug side effects
−6.416
−15.805
2.972
0.180
−4.936
−13.946
4.074
0.283
lDiagnosis
        
 Organic mental disorder
−3.878
−8.287
0.531
0.085
0.108
−4.311
4.528
0.962
 Psychoactive substance
−6.541
−10.309
−2.773
0.001
−2.659
−6.352
1.034
0.158
 Mood disorder
        
  Depression
−5.241
−7.357
−3.126
<0.001
−1.070
−3.636
1.496
0.413
  Bipolar disorder
−3.523
−5.756
−1.289
0.002
−1.696
−3.883
0.492
0.129
Neurotic, stress-related and somatoform disorders
−6.972
−9.156
−4.788
<0.001
−2.627
−5.205
−0.048
0.046
Behavioral syndrome with physiological disorders and somatic factors
−4.809
−27.637
18.018
0.679
−1.416
−23.230
20.398
0.899
Personality and behavioral disorders
−5.143
−14.530
4.245
0.283
−0.069
−9.122
8.983
0.988
Intellectual disability
16.191
−6.637
39.018
0.164
12.694
−8.841
34.228
0.248
Mental development disorder
       
Total dose of antipsychotics
0.012
0.009
0.014
<0.001
0.010
0.007
0.013
<0.001
aReference category = Male; bReference category = Married; cReference category = Primary school and below; dReference category = Retiree; eReference category = Living alone; fReference category = None substance abuse; gReference category = No suicidal ideation; hReference category = No insurance; iReference category = Admitted involuntarily; jReference category = No restrained or isolated; kReference category = Positive symptoms; lReference category = Schizophrenia Spectrum Disorder
Table 4 shows the factors affecting LOS in Chinese hospitals. We conducted multivariable regression with seven variables that were statistically significant in the univariable analysis and found that patients who were divorced, had suicidal ideation, were admitted involuntarily, were admitted because of physical, depression or anxiety symptoms, and who used greater dosages of antipsychotic drugs had longer hospitalisations (P < 0.05). Collinearity analysis showed that there was no obvious collinearity among all factors included in the multivariable linear model for America and China.
Table 4
Mixed linear regression model testing associations of predictors with LOS in Chinese hospital
Variables
Univariable linear regression
Multivariable linear regression
β
Cl(95%)
P
β
Cl(95%)
p
Lower bound
Upper bound
Lower bound
Upper bound
Age
−0.006
− 0.045
0.033
0.750
    
aGender
−1.066
−2.527
0.395
0.152
    
bMarital status
        
 Unmarried
1.533
0.002
3.063
0.050
1.248
−0.428
2.924
0.144
 Divorce
9.052
5.010
13.094
<0.001
7.209
3.352
11.067
<0.001
 Widowed
−0.616
−5.320
4.089
0.797
−2.154
−6.611
2.303
0.343
cEducation
        
 Junior middle school
1.634
−0.567
3.835
0.145
    
 High school
1.537
−0.566
3.640
0.152
    
 Junior college or undergraduate
0.745
−1.586
3.077
0.531
    
dOccupation
        
 Workers
1.589
−0.783
3.961
0.189
    
 Freelance worker
−0.125
−2.119
1.870
0.902
    
 Students
0.367
−2.163
2.897
0.776
    
 The unemployed
0.580
−2.119
3.278
0.674
    
eLiving condition
        
 Groups life
2.167
−10.990
15.324
0.747
    
fSubstance abuse
        
 Yes
−5.443
−10.741
−0.146
0.044
−4.063
−10.239
2.113
0.197
gSuicidal ideation
        
 Yes
5.921
4.508
7.334
<0.001
3.801
1.926
5.676
<0.001
hInsurance
        
 Yes
5.363
0.231
−3.420
0.231
    
iWhether or not to be admitted voluntarily
        
 Yes
−7.193
−8.655
−5.732
<0.001
−4.759
−6.765
−2.753
<0.001
jWhether restrained or isolated
        
 Yes
1.454
−0.693
3.601
0.184
    
kReasons for hospitalization
        
 Negative symptoms
−4.583
−7.943
−1.222
0.008
−1.744
−4.948
1.460
0.286
 Depression and anxiety
−1.102
−2.810
0.606
0.206
2.653
0.396
4.911
0.021
 Suicide and self-injury
−4.126
−7.046
−1.206
0.006
1.441
−1.901
4.783
0.398
 Physical symptoms
−3.221
−5.558
−0.885
0.007
4.323
1.382
7.265
0.004
 Substance abuse
−10.941
−20.232
−1.650
0.021
−1.916
− 13.965
10.133
0.755
 Drug side effects
1.859
−9.865
13.583
0.756
0.549
−10.469
11.568
0.922
lDiagnosis
        
 Organic mental disorder
−2.258
−4.301
− 0.216
0.030
−2.619
−5.150
−0.087
0.043
 Psychoactive substance
−8.545
−16.858
−0.232
0.044
−0.289
−11.717
11.140
0.960
 Mood disorder
        
  Depression
−2.756
−4.967
−0.546
0.015
−2.737
−5.668
0.193
0.067
  Bipolar disorder
0.891
−1.583
3.365
0.480
−0.790
−3.320
1.741
0.541
Neurotic, stress-related and somatoform disorders
−5.305
−7.438
− 3.172
<0.001
−3.032
− 5.819
− 0.244
0.033
Behavioral syndrome with physiological disorders and somatic factors
−5.132
−11.747
1.482
0.128
−3.973
−10.817
2.871
0.255
Personality and behavioral disorders
−8.945
−27.373
9.483
0.341
−4.602
− 22.010
12.806
0.604
Intellectual disability
0.841
−9.063
10.745
0.868
2.011
−7.350
11.372
0.674
Mental development disorder
−1.172
−9.107
6.763
0.772
−1.244
−8.837
6.349
0.748
Total dose of antipsychotics
0.013
0.010
0.017
<0.001
0.014
0.010
0.018
<0.001
aReference category = Male; bReference category = Married; cReference category = Primary school and below; dReference category = Retiree; eReference category = Living alone; fReference category = None substance abuse; gReference category = No suicidal ideation; hReference category = No insurance; iReference category = Admitted involuntarily; jReference category = No restrained or isolated; kReference category = Positive symptoms; lReference category = Schizophrenia Spectrum Disorder

Discussion

To our knowledge, this is the first study comparing the clinical characteristics of inpatients with psychiatric disorders in hospitals from Western China and America. Our results found differences in the sociodemographic and clinical characteristics of psychiatric inpatients. Most hospitalised patients were men in the American hospital and women in the Chinese hospitals. Furthermore, there were more unmarried and unemployed inpatients in the American hospital. The highest proportion of reasons for admission was suicide and self-injury symptoms in America and positive symptoms in China. Compared with China (1.9%), there were more inpatients with combined substance abuse in the American hospital (97.6%). The two most common diseases in hospitalised patients in these two countries were schizophrenia and mood disorders. Moreover, the LOS in the American hospital was shorter, but the total dosage of antipsychotic drugs was significantly higher than in the Chinese hospitals.
With regards to the higher percentage of psychiatric inpatients for substance use in America, it was noted that the proportion of patients diagnosed with psychoactive substances in American hospitals was also higher than that in China. There is a consensus that the incidence of mental disorders and comorbid substance abuse is very high [1214]. To illustrate, it is estimated that, in America, the lifetime prevalence of patients with mental disorders combined with some addictive disorder was 29.0%, alcohol dependence was 13.5%, and other drug dependence abuse was 6.1%. Moreover, 37% of those with an alcohol disorder had comorbid mental disorders. In addition, more than half (53%) of patients with drug addiction (excluding alcohol) had a mental disorder. Comorbidity rates of severe mental disorders, such as schizophrenia, bipolar disorder, and anti-social personality disorder, are particularly high, which makes treatment challenging [15]. In China, the most common use of psychoactive substances is drinking alcohol, with most other psychoactive substances being illegal and banned. Moreover, men are more likely to use alcohol than women [16, 17]. To illustrate, alcohol is widely used in China because a drinking culture of repetitive toasting plays a huge role in building relationships with business partners and friends; however, the rate may decrease due to the recent anti-corruption campaign in China which banned the provision of alcoholic beverages in government-sponsored meals [18]. However, the use of some psychoactive substances, such as cannabis, is legal in some states of America. Many states in America have legalised either its medical or its recreational use, making it easier to obtain. This leads to a marked increase in the prevalence of cannabis use, especially among subgroups [1922]. The above factors may explain why more psychiatric inpatients combined substance abuse. Furthermore, this highlights the need to focus on inpatients who are diagnosed with psychoactive substances in America in the future. Suicidal behaviour is a leading cause of injury and death worldwide. We found that the proportion of patients admitted because of attempted suicide and self-injury in America was higher than in China. The World Health Organization report indicates that in developed countries, suicide accounts for the largest share of intentional injury burden and the proportion of men is higher than women [23]. Risk factors for suicide include demographic, psychiatric, psychological, and stressful life events. Men with mental disorders, especially mood disorders and substance abuse, are at high risk for suicide [24]. Consistent with this, our results showed that these factors are higher in the American hospital.
Our data also showed that psychiatric LOS in America was significantly shorter than in China, but the total dosage of antipsychotic drugs was significantly higher. The LOS for mental disorders has decreased in America in recent decades [25]. These reductions have coincided with the reduction of public mental health services and an expansion in care provided in private psychiatric and general hospitals [26, 27]. Inpatient care constitutes the most expensive part of psychiatric services. To reduce expenditure, inpatients are required to be discharged as soon as possible [28]. The Healthcare Cost and Utilisation Project on mental health stays in American community hospitals in 2006 showed that the average LOS for mental health hospitalisation was less than 10 days [29]. Consistent with this, a recent report determined that the average LOS in an American inpatient setting was 10.0 ± 3.0 days [30]. Our results confirmed that the average LOS in an American hospital was 10.53 ± 11.91 days. There is consensus that psychotropic drugs usually take effect after 2–4 weeks [3134]. In China, after being discharged from the hospital, patients rely on family members to take care of them. These family members lack professional knowledge, making it difficult for them to observe improvement in symptoms and adverse drug reactions; thus, patients require a longer hospital stay. Although a reduction in LOS can reduce expenditure, it may lead to early discharge of patients who remain clinically unstable [35]. Furthermore, some studies have claimed that the shorter the hospital stay, the higher the relapse and readmission rate [36]. Therefore, more research is needed to determine which service system is more beneficial to patients. However, with updates to the guidelines, the requirements for rehabilitation of social function with mental illnesses have increased, and most patients may need to recover in the community in the future. Therefore, in China, the improvement of community services will also be a major challenge.
Furthermore, our results showed that the total dosage of antipsychotic drugs used in the American hospital was higher than in China. Ethnic differences in the dosage of antipsychotic drugs have been confirmed by many studies; Caucasians usually require higher antipsychotic dosages than Asians [3740]. The differential response and side effect profile of antipsychotics are related to genetic makeup, individual intrinsic factors, and cultural and contextual variables [4144]. Some data show that Caucasians are more likely to have received treatment for all psychiatric disorders (including bipolar disorder, anxiety, and substance use disorders) and have regular follow-ups [45]. Some articles have demonstrated lower clearance in the average East Asian population using antipsychotics due to metabolic activities [40]. These results may be because the dosage of drugs used in America is higher than in China. We found that there was a combination of antipsychotics inpatients with depression in both countries. In recent years, some studies have demonstrated that combining antidepressants and antipsychotics is significantly more effective to treat psychotic depression than using either antidepressant or antipsychotic monotherapy [46]. Most treatment guidelines recommend a combination of an antidepressant with an antipsychotic to treat an acute episode of unipolar psychotic depression [47]. Therefore, antipsychotic drugs are usually used in patients with depression, especially those with psychotic depression. Our results show that inpatients with depression in China used higher dosage of antipsychotics. It is indicated that there is more drug combination in China.
We also analysed the factors affecting the LOS in these two countries. The results showed that admission due to physical symptoms and the use of high-dosage drugs were related to longer LOS. In America, males also had longer hospitalisations, the LOS for male patients is longer, which may be related to the presence of more severe symptoms and higher drugs doses in male inpatients. In China, except for the above factors, patients who were divorced, had involuntary admissions, and experienced suicidal ideation had longer lengths of stay. Almost all studies have achieved consensus that patients with schizophrenia have the longest hospital stay among psychiatric conditions; this is because patients who suffer from severe mental illnesses need lengthier stays to achieve stabilisation and partial recovery [48, 49]. According to previous studies, older patients often have longer hospital stays due to the nature of their physical diseases [5052]. Comparatively, married patients have shorter stays because they usually have better emotional support and social networks, and family members, who can help patients to regularly take their medication and adhere to treatment plans [53]. In addition, due to the psychosocial nature of mental disorders, relatives’ active participation can enable patients to recover better. This may explain why unmarried and divorced patients had longer hospital stays in this study. Moreover, organic comorbidities are often accompanied by psychiatric problems and patients usually need consultations to reach a better clinical state, which leads to an increase in hospital stay [54, 55]. Patients in psychiatric wards who are restrained and isolated are usually those who have aggressive, impulsive, or violent behaviours; are less compliant with treatment procedures; and have negative attitudes towards medication. Additionally, physicians are more cautious in assessing the discharge of patients who may harm others; thus, longer hospitalisation is required to overcome these barriers [56]. This is consistent with the results of our study.
The main strength of this study is that it is the first to compare the clinical characteristics of psychiatric inpatients in these two countries in the East and West. In addition, the use of comprehensive clinical information, yielded significant results. Moreover, all information was collected through routine practice, which was not biased by any specific research protocol. These strengths ensure that the results reasonably reflect real-world situations. However, this study also had several limitations that should be highlighted. First, this was a retrospective study, and the data were collected by chart review, which might have led to observational bias. Second, we only selected three general hospitals from these two countries, thus, this study’s results should be interpreted with caution. Third, the type and name of other drugs were not obtained, such as mood stabilizers or anti-depressants, and only the dosages of chlorpromazine equivalent milligrams of antipsychotic drugs were included.
In conclusion, this study’s results highlighted the differences in the clinical characteristics of inpatients with psychiatric disorders in hospitals from Western China and America. Therefore, these findings serve as a starting point for determining the reasons behind these differences in future studies.

Acknowledgements

The authors are very grateful to the hospital from America Erie County Medical Center and all participants.

Declarations

All the procedures implemented in this study involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Ethics Committee and the Declaration of Helsinki. The study was approved by the Medical Ethics Committees of the three participanting hospitals (The First Affiliated Hospital of Xi’an Jiao Tong University, Xianyang Central Hospital and Erie County Medical Center). Because of the retrospective nature of this study, patient informed consent for inclusion was waived by the institutional review board of the First Affiliated Hospital of Xi’an Jiao Tong University, and the need for written informed consent was waived by the same committee that approved this study’s protocol.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Ma H, Liu J, He YL, et al. An important pathway of mental health service reform in China: introduction of 686 program. Chin Ment Health J. 2011;25(10):725–8. Ma H, Liu J, He YL, et al. An important pathway of mental health service reform in China: introduction of 686 program. Chin Ment Health J. 2011;25(10):725–8.
2.
Zurück zum Zitat Dwyer E. The final years of central state hospital. J Hist Med Allied Sci. 2019;74(1):107–26.CrossRef Dwyer E. The final years of central state hospital. J Hist Med Allied Sci. 2019;74(1):107–26.CrossRef
3.
Zurück zum Zitat Huang Y, Yu W, Hong W, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.CrossRef Huang Y, Yu W, Hong W, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.CrossRef
4.
Zurück zum Zitat Phillips MR, Zhang JX, Shi QC, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–53.CrossRef Phillips MR, Zhang JX, Shi QC, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–53.CrossRef
5.
Zurück zum Zitat Merikangas KR, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9.CrossRef Merikangas KR, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9.CrossRef
6.
Zurück zum Zitat Geller JL. Deinstitutionalization in 19th-century America. Hospital & Community Psychiatry. 1989;40(1):85–6. Geller JL. Deinstitutionalization in 19th-century America. Hospital & Community Psychiatry. 1989;40(1):85–6.
7.
Zurück zum Zitat Fazel S, et al. Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden. Lancet Psychiatry. 2014;1(1):44–54.CrossRef Fazel S, et al. Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden. Lancet Psychiatry. 2014;1(1):44–54.CrossRef
8.
Zurück zum Zitat Xiang YT, et al. Rethinking progress and challenges of mental health care in China. World Psychiatry. 2018;17(2):231–2.CrossRef Xiang YT, et al. Rethinking progress and challenges of mental health care in China. World Psychiatry. 2018;17(2):231–2.CrossRef
9.
Zurück zum Zitat Xiang YT, et al. Mental health in China: challenges and progress. Lancet. 2012;380(9855):1715–6.CrossRef Xiang YT, et al. Mental health in China: challenges and progress. Lancet. 2012;380(9855):1715–6.CrossRef
10.
Zurück zum Zitat Kane JM, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology consensus conference in Siena, Italy. Eur Neuropsychopharmacol. 1998;8(1):55–66.CrossRef Kane JM, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology consensus conference in Siena, Italy. Eur Neuropsychopharmacol. 1998;8(1):55–66.CrossRef
11.
Zurück zum Zitat Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663–7.CrossRef Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663–7.CrossRef
12.
Zurück zum Zitat Lamps CA, et al. Youth with substance abuse and comorbid mental health disorders. Curr Psychiatry Rep. 2008;10(3):265–71.CrossRef Lamps CA, et al. Youth with substance abuse and comorbid mental health disorders. Curr Psychiatry Rep. 2008;10(3):265–71.CrossRef
13.
Zurück zum Zitat Jones CM, et al. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78–82.CrossRef Jones CM, et al. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78–82.CrossRef
14.
Zurück zum Zitat Palomo T, et al. Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res. 2007;12(1):17–27.CrossRef Palomo T, et al. Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res. 2007;12(1):17–27.CrossRef
15.
Zurück zum Zitat Regier DA, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.CrossRef Regier DA, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.CrossRef
16.
Zurück zum Zitat Wei H, et al. Alcohol consumption and alcohol-related problems: Chinese experience from six area samples, 1994. Addiction. 1999;94(10):1467–76.CrossRef Wei H, et al. Alcohol consumption and alcohol-related problems: Chinese experience from six area samples, 1994. Addiction. 1999;94(10):1467–76.CrossRef
18.
Zurück zum Zitat Baxter AJ, et al. Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis. Lancet Psychiatry. 2016;3(9):832–41.CrossRef Baxter AJ, et al. Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis. Lancet Psychiatry. 2016;3(9):832–41.CrossRef
19.
Zurück zum Zitat Versteeg PA, et al. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg. 2008;6(4):315–20.CrossRef Versteeg PA, et al. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg. 2008;6(4):315–20.CrossRef
20.
Zurück zum Zitat Compton WM, et al. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103–7.CrossRef Compton WM, et al. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103–7.CrossRef
21.
Zurück zum Zitat Boyd CJ, et al. Adolescents' motivations to abuse prescription medications. Pediatrics. 2006;118(6):2472–80.CrossRef Boyd CJ, et al. Adolescents' motivations to abuse prescription medications. Pediatrics. 2006;118(6):2472–80.CrossRef
22.
Zurück zum Zitat Compton WM, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291(17):2114–21.CrossRef Compton WM, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291(17):2114–21.CrossRef
24.
Zurück zum Zitat Nock MK, Borges G, Bromet EJ, et al. Suicide and Suicidal Behavior. Oxford University Press. 2008;30(1):133–54. Nock MK, Borges G, Bromet EJ, et al. Suicide and Suicidal Behavior. Oxford University Press. 2008;30(1):133–54.
25.
Zurück zum Zitat Mechanic D, et al. Changing patterns of psychiatric inpatient care in the United States, 1988-1994. Arch Gen Psychiatry. 1998;55(9):785–91.CrossRef Mechanic D, et al. Changing patterns of psychiatric inpatient care in the United States, 1988-1994. Arch Gen Psychiatry. 1998;55(9):785–91.CrossRef
26.
Zurück zum Zitat Levinson D, et al. Reduction in inpatient length of stay and changes in mental health care in Israel over four decades: a national case register study. Isr J Psychiatry Relat Sci. 2003;40(4):240–7. Levinson D, et al. Reduction in inpatient length of stay and changes in mental health care in Israel over four decades: a national case register study. Isr J Psychiatry Relat Sci. 2003;40(4):240–7.
27.
Zurück zum Zitat Stefansson CG, et al. Mental health care reform in Sweden, 1995. Acta Psychiatr Scand. 2010;104(410):82–8. Stefansson CG, et al. Mental health care reform in Sweden, 1995. Acta Psychiatr Scand. 2010;104(410):82–8.
28.
Zurück zum Zitat BOd J, et al. Determinants of length of stay in the psychiatric wards of the university college hospital, Ibadan, Nigeria. Afr J Med Med Sci. 2012;41(2):147–52. BOd J, et al. Determinants of length of stay in the psychiatric wards of the university college hospital, Ibadan, Nigeria. Afr J Med Med Sci. 2012;41(2):147–52.
30.
Zurück zum Zitat Lee S, et al. Length of inpatient stay of persons with serious mental illness: effects of hospital and regional characteristics. Psychiatric Services. 2012;63(9):889–95.CrossRef Lee S, et al. Length of inpatient stay of persons with serious mental illness: effects of hospital and regional characteristics. Psychiatric Services. 2012;63(9):889–95.CrossRef
31.
Zurück zum Zitat Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs. 2005;19(1):1–93. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs. 2005;19(1):1–93.
32.
Zurück zum Zitat EM A, et al. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant–submissive relationships. Neurosci Biobehav Rev. 2007;31(6):904–19.CrossRef EM A, et al. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant–submissive relationships. Neurosci Biobehav Rev. 2007;31(6):904–19.CrossRef
33.
Zurück zum Zitat Lam RW. Onset, time course and trajectories of improvement with antidepressants. Eur Neuropsychopharmacol. 2012;22(Suppl 3):S492–8.CrossRef Lam RW. Onset, time course and trajectories of improvement with antidepressants. Eur Neuropsychopharmacol. 2012;22(Suppl 3):S492–8.CrossRef
34.
Zurück zum Zitat Keck PE Jr, et al. Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry. 1989;146(10):1289–92.CrossRef Keck PE Jr, et al. Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry. 1989;146(10):1289–92.CrossRef
35.
Zurück zum Zitat Masters GA, et al. Factors associated with length of psychiatric hospitalization. Compr Psychiatry. 2014;55(3):681–7.CrossRef Masters GA, et al. Factors associated with length of psychiatric hospitalization. Compr Psychiatry. 2014;55(3):681–7.CrossRef
36.
Zurück zum Zitat Miettunen J, et al. Patterns of psychiatric hospitalizations in schizophrenic psychoses within the northern Finland 1966 birth cohort. Nord J Psychiatry. 2006;60(4):286–93.CrossRef Miettunen J, et al. Patterns of psychiatric hospitalizations in schizophrenic psychoses within the northern Finland 1966 birth cohort. Nord J Psychiatry. 2006;60(4):286–93.CrossRef
37.
Zurück zum Zitat Rosenblat R, et al. Do oriental psychiatric patients receive different dosages of psychotropic medication when compared with occidentals. Can J Psychiatry. 1987;32(4):270–4.CrossRef Rosenblat R, et al. Do oriental psychiatric patients receive different dosages of psychotropic medication when compared with occidentals. Can J Psychiatry. 1987;32(4):270–4.CrossRef
38.
Zurück zum Zitat Marazziti D, et al. The increasing challenge of the possible impact of ethnicity on psychopharmacology. CNS spectrums. 2021;26(3):222–31.CrossRef Marazziti D, et al. The increasing challenge of the possible impact of ethnicity on psychopharmacology. CNS spectrums. 2021;26(3):222–31.CrossRef
39.
Zurück zum Zitat Hassan A, et al. Association of ethnicity with antipsychotic dosage using STRUCTURE analysis. Pharmacopsychiatry. 2013;46(4):151–5.CrossRef Hassan A, et al. Association of ethnicity with antipsychotic dosage using STRUCTURE analysis. Pharmacopsychiatry. 2013;46(4):151–5.CrossRef
40.
Zurück zum Zitat Ruan CJ, Zang YN, Wang CY, Cheng YH, Sun C, Spina E, et al. Clozapine metabolism in east Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review. J Clin Psychopharmacol. 2019;39(2):135–44.CrossRef Ruan CJ, Zang YN, Wang CY, Cheng YH, Sun C, Spina E, et al. Clozapine metabolism in east Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review. J Clin Psychopharmacol. 2019;39(2):135–44.CrossRef
41.
Zurück zum Zitat Kim K, et al. Differences in drug pharmacokinetics between east Asians and Caucasians and the role of genetic polymorphisms. J Clin Pharmacol. 2004;44(10):1083–105.CrossRef Kim K, et al. Differences in drug pharmacokinetics between east Asians and Caucasians and the role of genetic polymorphisms. J Clin Pharmacol. 2004;44(10):1083–105.CrossRef
42.
Zurück zum Zitat Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet. 1995;29(3):192–209.CrossRef Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet. 1995;29(3):192–209.CrossRef
43.
Zurück zum Zitat Lin KM, et al. Culture and psychopharmacology. Psychiatr Clin North Am. 2001;24(3):523–38.CrossRef Lin KM, et al. Culture and psychopharmacology. Psychiatr Clin North Am. 2001;24(3):523–38.CrossRef
44.
Zurück zum Zitat Wood AJ. Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med. 2001;344(18):1394–6.CrossRef Wood AJ. Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med. 2001;344(18):1394–6.CrossRef
45.
Zurück zum Zitat Cook B, et al. Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse. Drug Alcohol Depend. 2018;187:29–34.CrossRef Cook B, et al. Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse. Drug Alcohol Depend. 2018;187:29–34.CrossRef
46.
Zurück zum Zitat Farahani A, et al. Are antipsychotics or antidepressants needed for psychotic depression? J Clin Psychiatry. 2012;73(4):486–96.CrossRef Farahani A, et al. Are antipsychotics or antidepressants needed for psychotic depression? J Clin Psychiatry. 2012;73(4):486–96.CrossRef
47.
Zurück zum Zitat Mcallister-Williams RH, et al. The identification, assessment and management of difficult-to-treat depression: an international consensus statement. J Affect Disord. 2020;15(267):264–82.CrossRef Mcallister-Williams RH, et al. The identification, assessment and management of difficult-to-treat depression: an international consensus statement. J Affect Disord. 2020;15(267):264–82.CrossRef
48.
Zurück zum Zitat Tavalaei A, et al. Length of stay at psychiatry Ward in Baqyiatallah(a.s.). Hospital Milmed J. 2007;9(1):43–50. Tavalaei A, et al. Length of stay at psychiatry Ward in Baqyiatallah(a.s.). Hospital Milmed J. 2007;9(1):43–50.
49.
Zurück zum Zitat Chung W, et al. Determinants of length of stay for psychiatric inpatients: analysis of a national database covering the entire Korean elderly population. Health Policy. 2010;94(2):120–8.CrossRef Chung W, et al. Determinants of length of stay for psychiatric inpatients: analysis of a national database covering the entire Korean elderly population. Health Policy. 2010;94(2):120–8.CrossRef
50.
Zurück zum Zitat Ithman MH, et al. Predictors of length of stay in an acute psychiatric hospital. J Health Educ Res Dev. 2014;2(2). Ithman MH, et al. Predictors of length of stay in an acute psychiatric hospital. J Health Educ Res Dev. 2014;2(2).
51.
Zurück zum Zitat Jiménez R, et al. Observed-predicted length of stay for an acute psychiatric department, as an indicator of inpatient care inefficiencies. Retrospective case-series study. BMC Health Serv Res. 2004;4(1):4.CrossRef Jiménez R, et al. Observed-predicted length of stay for an acute psychiatric department, as an indicator of inpatient care inefficiencies. Retrospective case-series study. BMC Health Serv Res. 2004;4(1):4.CrossRef
52.
Zurück zum Zitat Liu CM, et al. Determinants of psychogeriatric inpatient length of stay and direct medical costs: a 6-year longitudinal study using a national database in Taiwan. Psychiatry Clin Neurosci. 2012;66(5):423–31.CrossRef Liu CM, et al. Determinants of psychogeriatric inpatient length of stay and direct medical costs: a 6-year longitudinal study using a national database in Taiwan. Psychiatry Clin Neurosci. 2012;66(5):423–31.CrossRef
53.
Zurück zum Zitat Yu YH, et al. Schizophrenia, social support, caregiving burden and household poverty in rural China. Soc Psychiatry Psychiatr Epidemiol. 2020;55(12):1571–80.CrossRef Yu YH, et al. Schizophrenia, social support, caregiving burden and household poverty in rural China. Soc Psychiatry Psychiatr Epidemiol. 2020;55(12):1571–80.CrossRef
54.
Zurück zum Zitat Ukpong D, et al. Demographic and clinical correlates of length of stay in a Nigerian university hospital psychiatric unit. Türk psikiyatri dergisi. 2009;20(1):49–55. Ukpong D, et al. Demographic and clinical correlates of length of stay in a Nigerian university hospital psychiatric unit. Türk psikiyatri dergisi. 2009;20(1):49–55.
55.
Zurück zum Zitat Douzenis A, et al. Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Serv Res. 2012;12:166.CrossRef Douzenis A, et al. Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Serv Res. 2012;12:166.CrossRef
56.
Zurück zum Zitat Gopalakrishna G, et al. Predictors of length of stay in a psychiatric hospital. Int J Psychiatry Clin Pract. 2015;19(4):238–44.CrossRef Gopalakrishna G, et al. Predictors of length of stay in a psychiatric hospital. Int J Psychiatry Clin Pract. 2015;19(4):238–44.CrossRef
Metadaten
Titel
A comparison of clinical characteristics of psychiatric inpatients in three hospitals from Western China and America
verfasst von
Min Jia
Bang An
Bin Yan
Qingyan Ma
Binglong Wen
Shanshan Zhao
Chengge Gao
Xiancang Ma
Lili Zhang
Bin Li
Ping Zhang
Jian Wang
Hong Yu
Wei Wang
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Psychiatry / Ausgabe 1/2023
Elektronische ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-022-04500-2

Weitere Artikel der Ausgabe 1/2023

BMC Psychiatry 1/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.